The Ins and Outs of Newborn Screening
Dear colleague,
Despite remarkable advances enabling screening for hundreds of treatable disorders, newborn screening programmes still vary widely across healthcare systems.
We invite you to join us for the first of two courses organised in Amsterdam, from 12–14 October 2026 for an intensive, 3-day interactive course designed to navigate the complexities of current and future screening programmes.
We look forward to seeing you in Amsterdam.
Scientific Organising Committee
Dr Robin Lachmann
Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, London
Prof. Stefan Kölker
Head of the Division of Inherited Metabolic Diseases. University Children’s Hospital, Heidelberg
Prof. Angeles Garcia-Cazorla
Professor of Paediatric Neurology and Neurometabolism, University of Barcelona
Prof. Fanny Mochel
Professor of Medical Genetics and Neurometabolism, Sorbonne University, Paris
Samantha Barber
Chief Executive of Gene People, London
